• Axon Enterprise recently reported strong Q4 2025 results, with revenue growth driven by demand for premium software, TASER 10, Axon Body 4, and counter-drone solutions, alongside upbeat guidance for 2026 and long-term 2028 revenue targets.
• At the same time, the company’s board will see change as director Julie Anne Cullivan has decided not to stand for re-election at the 2026 Annual Meeting, highlighting ongoing governance evolution alongside Axon’s product and earnings momentum.
• With Axon’s robust 2025 results and confident multi-year guidance now on the table, we’ll examine how this reshapes its investment narrative.

Find 49 companies with promising cash flow potential yet trading below their fair value.

Axon Enterprise Investment Narrative Recap

To own Axon Enterprise, you need to believe that public safety agencies will keep shifting budgets toward integrated TASER devices, body cameras, and cloud software, and that Axon can keep deepening those relationships. The main near term catalyst is execution against its 2026 and 2028 revenue targets, while the biggest risk is Axon’s reliance on government budgets and sentiment toward law enforcement. Julie Anne Cullivan’s planned board exit does not materially change either factor.

The most relevant recent announcement here is Axon’s Q4 2025 earnings release, which put concrete numbers behind that thesis: US$796.7 million in quarterly revenue and full year 2025 revenue of US$2.78 billion, alongside guidance for 27 percent to 30 percent revenue growth in 2026. Those figures, driven by products like TASER 10, Axon Body 4 and counter drone tools, are central to whether Axon can sustain its upsell and software heavy, recurring revenue catalyst.

Yet despite these strong numbers, investors should be aware that Axon’s dependence on government funding and procurement cycles could...

Axon Enterprise's narrative projects $4.6 billion revenue and $476.0 million earnings by 2028.

Uncover how Axon Enterprise's forecasts yield a $815.00 fair value, a 62% upside to its current price.

Exploring Other Perspectives

Some of the most bearish analysts, who were assuming revenue of about US$4.0 billion and earnings of roughly US$554 million by 2028, focus on risks like commoditization and stricter privacy rules compressing margins, which contrasts with the more upbeat view of rapid AI and software adoption, reminding you that this new guidance and board change may shift both narratives in very different ways.

Explore 11 other fair value estimates on Axon Enterprise - why the stock might be worth as much as 66% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Axon Enterprise research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Axon Enterprise research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Axon Enterprise's overall financial health at a glance.

Searching For A Fresh Perspective?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.
• Uncover the next big thing with 32 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.